Biometrics — technologies that allow people to be identified by fingerprints or other biological markers, such as iris scans — is receiving increased attention by companies in many industries concerned about security, not only for their premises but also for their information systems and the valuable, proprietary data within.
Executives at Purdue Pharma understand all too well that the war on drugs isn’t limited to heroin and cocaine. Since 2000, Purdue has been involved in controversy regarding the illegal use and abuse of OxyContin, an opioid agonist for the treatment of pain that the company introduced in 1995.
To enhance the security of its facilities, Purdue Pharma has implemented a biometrics technology — fingerprint readers that work with the company’s swipe-card access system — for its manufacturing, packaging, and Q&A areas.
“Employees swipe their card, which is a ‘smart card’ that contains a fingerprint protocol,” says Aaron Graham, VP of corporate security at Purdue Pharma. “The card tells the computer that I am Aaron Graham. Then I put my fingerprint on the reader. The fingerprint has to match the smart-card ID information for me to gain entry or access…
The Biometrics World
Biometrics Industry Revenue
Biometrics Revenue Projections by Market Segment
Biometrics Technologies and Revenue Projections
Losses by the Numbers
Experts on this Topic
Reza Adhami, Ph.D. Professor and Chairman of the Department of Electrical and Computer Engineering, University of Alabama in Huntsville, Huntsville, Ala.; The Department of Electrical and Computer Engineering offers undergraduate engineering programs, master’s degree programs, and Ph.D. programs in several areas of engineering, including computer engineering, electrical engineering, software engineering, photonics engineering, and optical science and engineering. For more information, visit uah.edu. Seth Birnbaum. CEO and Cofounder of Verdasys Inc., Waltham, Mass.; Verdasys provides a class of risk-management solutions focused on the uncountered threat from authorized users or insiders. For more information, visit verdasys.com.
Michael M. Breggar, DPM. Global Director, Life Sciences Practice, Life Sciences and Healthcare Regulatory, Deloitte & Touche LLP, Glen Mills, Pa.; Deloitte & Touche LLP’s Health Care & Life Sciences Practice, with U.S. headquarters in New York, works with clients to shape the evolution of the industry. For more information, visit deloitte.com/us/healthcare.
Marc Diament. Executive VP, Business Development, Net-Scale Technologies Inc., Morganville, N.J.; Net-Scale Technologies specializes in innovative, high-quality software design and development for the telecommunications, healthcare, manufacturing, government and defense, and customer-relations management industries. For more information, visit net-scale.com.
Clyde Fritz. Director of Enterprise Integration, Alliance Consulting, New York.; Alliance Consulting is an information technology consulting firm that delivers business-driven solutions. For more information, visit alliance-consulting.com.
Aaron Graham. VP of Corporate Security, Purdue Pharma LP, Stamford, Conn.; Purdue Pharma is a privately held pharmaceutical company known for its pioneering research on chronic pain. For more information, visit pharma.com.
Cliff Kittle. Director, Sales, Emerging Markets, Saflink Corp., Woodstock, Ill.; Saflink, with headquarters in Bellevue, Wash., offers software solutions designed to protect intellectual property, secure information assets, and eliminate passwords. For more information, visit saflink.com.
Raj Nanavati. Partner, International Biometric Group LLC, New York; IBG is an independent integration and consulting firm, providing a broad range of services to government and private sector clients. For more information, visit biometricgroup.com.
Nicholas Stamos. VP, Products and Services and Cofounder, Verdasys Inc., Waltham, Mass.; Verdasys provides a class of risk-management solutions focused on the uncountered threat from authorized users or insiders. For more information, visit verdasys.com.